Circulating polymorphonuclear leukocytes (PMN)' exhibit negligible binding affinity for unstimulated vascular endothelium (EC). After intravenous administration ofa chemotactic factor such as C5a, PMN attach to EC as evidenced by a rapid (<1 min) neuropenia (1, 2), but they soon detach and normal levels of circulating PMN are restored in 15-20 min. Thus PMN possess the means oftransiently making then breaking adhesions to EC. Transient adhesion of PMN to EC appears necessary for extravasation in response to a chemotactic signal . A gradient ofchemotactic agent emanating from the surrounding tissues causes PMN first to bind to the lu minal surface of the EC, then to break that adhesion as they move out of the vascular space .
EC in excess of PMN, and yielded consistent and quantifiable adherent PMN without disrupting the EC during the assay. Adhesion was allowed to proceed for 15 min at 37°C, and unbound PMN were removed by three washes with M199. Residual adherent PMN on EC surfaces were counted manually on an inverted microscope (DiaphotTMD ; Nikon Inc., Garden City, NY) equipped for fluorescence using the filter IF535-550 . Values of five replicates were averaged, and variations between replicates were small (<10%) . The adhesion of maximally stimulated PMN was very consistent from experiment to experiment, but the adhesion of unstimulated PMN varied considerably. Thus, the enhancement of adhesion by stimulants varied from 3 to 10-fold . The background binding observed in the absence of stimulants was partially inhibitable with anti-CD18 mAb IB4 .
In experiments where PMN were treated with PDB (300 ng/ml), TNF (0.66 nM), or C5a (10-sM), Dil-labeled PMN were treated with agonists for various times at 37°C, washed three times with HAP buffer, and resuspended in M199 before the adhesion assay. Preliminary experiments showed these concentrations of agonists yielded optimal enhancement of adhesion of PMN to EC. Treatment of PMN with any of these agonists did not alter PMN viability, as judged by exclusion of trypan blue.
In experiments using mAbs to inhibit adhesion, PMN were treated with PDB for 15 min at 37°C, washed three times with HAP buffer, and incubated with various mAbs (10 wg/ml) for 20 min at 0°C before the adhesion assay. mAbs were present with the PMN-EC coculture throughout the assay.
Preparation and Characterization ofPMN Cytoplasts . Cytoplasts were prepared by centrifuging cytochalasin B-treated PMN on a two-step Ficoll gradient exactly as described (19) . Cytochalasin B was removed by washing the cytoplasts five times with incubation medium (138 mM NaCl, 2.7 mM KCI, 8.1 mM Na2HP04, 1.5 mM KH2PO4, 0.6 mM CaC12, 1.0 MM MgCl2, 5.5 mM glucose, and 0.5% (wt/vol) human albumin) . The yield of the cytoplast preparation was >98%. Cytoplasts were either used immediately or frozen with 20% DMSO as described (19) , and were used within a month .
To confirm that cytoplasts were free of granular constituents, the activities of several enzyme markers were assayed and compared with those ofwhole PMN ( Table 1) . ß-glucuronidase (20) , myeloperoxidase (21) , vitamin 1312-binding protein (22) , and alkaline phosphatase (23) were assayed by standard procedures. The cytoplasts had about one-third of the activity of alkaline phosphatase found in whole PMN (Table I) , which is consistent with a report that cytoplasts have a surface area about one-third as great as that of whole cells (19) . Enzymatic activity of granule constituents in our cytoplast preparation was <4% that of whole PMN, confirming previous reports (19) that cytoplasts are deficient in both specific and azurophilic granules . The absence of granules within cytoplasts was confirmed by electron microscopy (not shown).
Expression of Cell Surface Antigens. Expression of CDllb/CD18 on the surface ofPMN and Vitamin B12-binding protein (specific granule) 5 .9 ng/ml 0.1 ng/ml cytoplasts was measured by flow cytometry. PMN or cytoplasts were labeled with 5 kg/ml FITC-conjugated OKMI for 20 min at 0°C and analyzed with a Becton Dickinson FACScan cell analyzer. Nonspecific fluorescence was determined in parallel preparations incubated with 20-fold excess unlabeled OKMI. To measure the expression of CDl1a/CD18, cells were incubated at 0°C for 20 min with 5 pg/ml TSl/22, washed, and incubated with 10,ug/ml FITCconjugated goat anti-mouse IgG (HyClone Laboratories Inc.). The intensity of fluorescence was subsequently analyzed by FAGS. The expression of CDllb/CD18 on cytoplasts stimulated with PDB (300 ng/ml for 15 min at 37°C) was measured to determine if depletion of granules abolished intracellular storage pools ofCDllb/CD18 . Unlike intact PMN, cytoplasts did not exhibit any increase in the surface expression of CDilb/CD18 upon PDB stimulation (Table II) .
Results
Adhesion ofStimulation PMNto EC Is CD111CD18 Dependent. DiI-labeled PMN were used to assay the adhesion ofunstimulated and PDB-stimulated PMN to EC. Without stimulation, very few PMN bound to EC ( Fig. 1 a and b) . In contrast, when PMN were treated with PDB (300 ng/ml) for 15 min at 37°C, increased numbers of adherent PMN were observed ( Fig. 1 c and d ). Based on counts made before and after washing, N50% of the added PMN bound to EC. PMN adhered as individuals rather than aggregates, and the integrity of the EC monolayers was not altered during the adhesion assay ( Fig. 1 a and c) .
The adhesion of PMN to EC observed in our assay is mediated entirely by the CDII/CD18 complex on PMN . Treating PDB-stimulated PMN with mAb IB4 against CD18 before the incubation with EC completely abrogated the adhesion of PMN to EC (Fig. 2) . Fab fragments of IB4 also had potent inhibitory activities, indicating that the Fc portion of the mAb is not involved in the inhibition of PMN adhesion (Fig. 3) . Several other anti-CD18 mAbs (H52, MHM23, 60.3, and TSl/18) had a similar potent inhibitory effect on binding ofPDB-stimulated PMN to EC, but control mAbs against other determinants on PMN were without inhibitory effects (Fig.  3 , and see below) . Further evidence for the role of CDII/CD18 in adhesion was derived from studies on PMN from two patients with a genetic deficiency in CD11/CD18 . These cells failed to adhere to EC, even after stimulation with PDB (Fig. 2) . These results confirm the primacy of CDII/CD18 in adhesion to unstimulated EC and demonstrate that our EC do not exhibit CDII/CD18-independent adhesion characteristic of stimulated EC (4, 24) .
CD11a/CD18 and CD11b/CD18, but not CD11c/CD18 Mediate Phorbol-enhanced PMN Adhesion of PMNto EC. To determine which individual members of the CDII/CD18 complex were responsible for the adhesion of phorbol-treated PMN to EC, adhesion Cytoplasts (106 cells/ml) were treated with PDB (300 ng/ml) for 15 min at 37°C, washed, and stained with FITC-OKM1 (10 ug/ml) for 20 min on ice . Fluorescence was analyzed by flow cytometry . was measured in the presence of mAbs against CD11a, CD11b, or CD11c (see Materials and Methods). mAb TSl/22 against CDlla and OKM10 against CD11b each inhibited binding of stimulated PMN by -66% (Fig. 3 ) . mAb LeuM5 against CD11c caused no inhibition (Fig. 3 ). The inhibition caused by mAbs was unlikely to be due to a steric effect since mAb 3G8, directed against FcRIII on PMN, had virtually no effect on adhesion (percent inhibition = 5%) ( Fig. 3) , and Fc receptors are more abundant on the cell surface than CDllb/CD18 or CDlla/CD18 (9). The inhibition of binding caused by anti-CD11a and CDllb was partial, yet the inhibition by anti-CD18 was nearly complete (>90%), suggesting that CDlla/CD18 and CD11b/CD18 may both function in adhesion of stimulated PMN to EC. This was confirmed by the observation that a mixture ofmAbs OKM10 and TS1/22 had an additive inhibitory effect on adhesion (percent inhibition = 93%) (Fig. 3) . The combined inhibitory effect ofanti-CD11a and CD11b mAbs was similar to that achieved by anti-CD18 mAbs (Fig. 3 ). These data suggest that CDlla/CD18 and CDllb/CD18 CDll/CD18-dependent adhesion of stimulated PMN to EC. The adhesion of PMN from a normal donor and two CD18-deficient patients was assayed as described in Materials and Methods. Where indicated, PMN were stimulated with 300 ng/ml PDB for 15 min at 37'C before the assay. PDBtreated PMN were treated with mAb IB4 as described in Materials and Methods. These data were confirmed by a second experiment that gave similar results . . CDlla/CD18 and CDllb/CD18 but not CDllc/CD18, mediate phorbol-enhanced adhesion of PMN to EC . Dil-labeled PMN were stimulated with 300 ng/ml PDB for 15 min at 37'C, treated with mAb as described in Materials and Methods, and adhesion to EC was assayed. The data are means of five to seven experiments, and error bars indicate SEM.
each mediate adhesion of phorbol-stimulated PMN to EC, that each makes a comparable contribution, and that CD11c/CD18 makes very little if any contribution to adhesion . The Capacity ofCD11/CD18 to MediateAdhesion ofPMN to EC Is Transiently Stimulated by Phorbol Esters. We previously showed that the capacity of CD11b/CD18 on PMN to bind to erythrocytes coated with complement fragment C3bi (EC3bi) is transiently enhanced upon stimulation of the cells with phorbol esters (9) . To determine if CDll/CD18-dependent binding of PMN to EC is regulated in a similar fashion, PMN were incubated for various intervals with PDB at 37°C, then assayed for adhesion to EC. The binding of PMN to EC increased sharply after 15 min of stimulation and then fell below control levels by 60 min (Fig. 4) . The time course of these changes in binding activity was identical with that for the binding of EC3bi by phorbol-treated PMN (9) . The loss of binding activity after 60 min of stimulation by PDB was not caused by cell death, as >95To of PMN excluded trypan blue after treatment with PDB for 60 min. Furthermore, the loss of adhesivity required active metabolism, since PMN incubated with PDB for 15 min at 37°C retained high binding activity to EC after a 1-h incubation at 4°C (data not shown) .
Transient Binding Activity Induced by Physiological Stimuli. It has been reported that the physiological mediators TNF and C5a cause enhanced adhesion of PMN to EC (25, 26) , and we next asked whether enhancement by these agents is also transient. Pretreatment of PMN with TNF (0.66 nM) caused a rise and subsequent fall in binding activity with a time course similar to that seen with PDB (Fig. 4) . C5a (10 -8 M) also caused a similar transient increase in binding activity (Fig. 5 ), but the peak occurred before 15 min. To accurately follow the time course ofC5a-stimulated adhesivity, we added C5a (10-8 M) directly to cocultures of PMN and EC and incubated them for different times . C5a caused strong adhesion of PMN to EC as early as 2 min, and maximum adhesion was observed at 5 min. Adhesion of PMN to EC returned to basal levels by 15-20 min (Fig. 5 ). The adhesion stimulated by both C5a and TNF is CD11/CD18 dependent, since both were completely blocked by treating PMN with soluble mAb IB4 (data not shown) .
Detachment ofPMNfrom EC. Upon stimulation of cells with C5a, PMN first adhered to and then detached from the EC (Fig . 5) to EC was mediated by CD11/CD18, we presume the subsequent detachment was associated with release of ligand by these adhesive receptors. It is unlikely that release is due to an irreversible process such as proteolysis of receptors or ligands because adhesion could be rapidly reestablished by restimulation of the cells. Adhesion of PMN was initiated by stimulation of cells for 5 min with C5a (10' 8 M). Nonadherent cells were removed by washing, and during a subsequent 15 min at 37'C, the PMN were observed to detach (Fig. 6) . Restimulation of the detached cells for 5 min with PDB (300 ng/ml) or TNF (0.66 nM) caused rebinding of PMN to EC. In contrast, C5a restimulation did not cause the detached PMN to re-adhere to EC. The second enhancement in PMN adhesion was also CD11/CD18 dependent since it was blocked by mAb IB4 (data not shown) .
Regulation of Binding of PMN to EC Does Not Correlate with Changes in Expression of CD11a/CD18 and CD11b/CD18 . To determine whether the increase and subsequent decrease in CDll/CD18-dependent binding ofPMN to EC was associated wtih quan- Restimulation of C5a-stimulated adhesion of PMN to EC . PMN were layered on EC and exposed to C5a (10-8 M) for 5 min at 37°C by which time the ability of PMN to adhere to EC had reached maximum (see Fig. 5 ) . Unbound PMN were removed b A the ah, The Teasaki plrewsesrt containing adherent PMN on I EC were incubated for an additiona115 min at 37°C, to allow adherent PMN to detach from EC . PDB (300 ng/ml), TNF C5o (5'), wash, reincubate (0 .66 nM), or C5a (10-8 M) was then added to the PMN-EC cocultures, and adhesion was allowed to continue for an additional 5 min at 37°C . Adherent PMN were scored after nonadherent PMN were removed by three washes with M199 . The experiment shown here is representative of three separate experiments. Error bars indicate the standard deviation of the mean. titative changes in the cell surface receptors, the expression of CD11a/CD18 and CD11b/CD18 on PMN stimulated with agonists for different lengths of time was measured by flow cytometry.
CDIIa/CD18. Treatment of PMN with PDB (300 ng/ml) caused little change in the expression in CD11/a/CD18 at any time from 0 to 60 min (Fig. 7) . Similarly, neither TNF nor C5a caused changes in the expression of CD11a/CD18 on the cell surface (data not shown) . These data confirm the observations of other investigators (9, 27) who showed that CDlla/CDl8 expression is not changed upon stimulation ofPMN. Phorbol-stimulated changes in adhesion ofPMN to EC cannot, therefore, be accounted for by changes in the number of CDlla/CD18. CD1Ib/CD18. PDB (300 ng/ml) caused a rapid 2.7-fold increase in the expression of CD11b/CD18 that reached maximum at 15 min and remained at above twofold for 60 min (Fig. 7) . While the time course ofthe increased expression was comparable to that for increased adhesion, this change in expression is insufficient to explain the transient changes in adhesivity. The 2-3-fold increase in CD11/CD18 expression is much less than the 3-10-fold increase in adhesion observed after 15 min of stimulation. More importantly, expression of CDllb/CD18 remained high for 60 min, during which time the capacity ofPMN to bind to EC fell to baseline levels .
PMN treated with TNF (0.66 nM) exhibited a rapid and sustained rise in the expression of CDllb/CD18, with a time course differing from that of the binding activity (Fig. 8 ). An increase in the expression of CD11b/CD18 was also observed when PMN were treated with C5a (10-8 M) (Fig. 8) . Although the initial rate of increase was similar to that seen with TNF, the maximum expression by 10-15 min was lower than with TNF, and the amount of CD11b/CD18 on the cell surface subsequently declined to that observed before stimulation. For treatment with either TNF of C5a, the time course of change in the expression of CDllb/CD18 does not correlate well with that for changes in binding activity. These observations suggest that changes in the expression of CDllb/CD18 on the cell surface may contribute to the transient enhancement of binding activity but do not provide a complete explanation for this phenomenon.
Cytoplasts Bind Transiently to EC. To test the hypothesis that a mechanism unrelated to changes in the expresssion of CDllb/CD18 functions to regulate attachment of PMN to EC, we employed cytoplasts, which are depleted ofthe intracellular granules that act as storage pools of CD11b/CD18 . Flow cytometry was used to measure the expression of CDllb/CD18 on the surface of cytoplasts treated with PDB, and no significant increase was observed at times up to 60 min (Fig. 9) . Resting cytoplasts bound poorly to EC, but stimulation for 15 min with PDB caused a fourfold enhancement in binding. Further incubation with PDB caused binding to return to baseline levels by 60 min. Thus transient changes in the adhesion capacity of CD11/CD18 may occur in the absence ofalteration in the surface expression of these molecules and in the absence of granule contents . Discussion Adhesion of PMNto EC Is Mediated by Two Members ofthe CD111CD18 Complex. Essentially all of the adhesion of stimulated PMN to unstimulated EC we observed in our assay was dependent on CD11/CD18 molecules on the PMN. Anti-CD18 mAbs blocked adhesion completely, and PMN from CD11/CD18 deficient patients did not adhere (Fig. 2) . However, other mechanisms for adherence of PMN to EC do exist.
Several laboratories have shown that stimulation of EC for several hours with either LPS, IL-1, or TNF results in strong adherence of PMN that does not require CD11/CD18 expression (24, 28, 29) . We have also observed CD11/CD18-independent adhesion on EC stimulated with TNF for 3 h (unpublished observations). These observations confirm that our EC are sensitive to stimulation and our assay can detect adhesions mediated by other mechanisms, but that these other mechanisms are not operative in our experiments. Our EC thus resemble naive, unstimulated EC, and our system best models the rapid (1-15 min) binding of PMN to EC observed after the introduction of an inflammatory stimulus into tissues in vivo. The rapid time course of action ofthe stimuli used (PMA, TNF, C5a) is consonant with this view.
The adherence of maximally stimulated PMN appears to use CDlla/CD18 and CD11b/CD18 to an approximately equal degree. Antibodies against CD11a and CD11b inhibited binding to a similar extent (6670) and a combination of anti-CDlla and anti-CD11b completely blocked binding (Fig. 3) . CD11c/CD18, on the other hand, did not appear to contribute to the adhesion measured here. It is not clear whether this reflects an intrinsic inability of CDllc/CD18 to mediate adhesion to EC or if it reflects the source of endothelial cells:Nhile CD11a/CD18 is known to recognize the molecule ICAM-1 (30, 31) , the identity of the ligands on EC recognized by CDllb/CD18 is not known. It is also not known whetherCD11b/CD~8 or CD11c/CD18 can recognize ICAM-1.
Relationship of TransientAdhesion to PMNFunction In Viva The abilityof CD11/CD18 to mediate binding to EC was transiently stimulated by PMA, TNF, and C5a. Maximal binding in response to C5a occurred after 5 min of stimulation but receded to baseline levels after 15 min (Fig. 5) . This response mirrors the rapid, transient neutropenia observed in animals injected intravenously with C5a (1, 2). A slower time course of adhesion was observed for PMN treated with PMA and TNF, with maximal binding after 15 min and a return to baseline adhesion by 60 min. These times correspond well with the transient neutropenia observed in rabbits injected intravenously with TNF (32) .
Transient adhesion of PMN to EC may represent an important aspect oftransendothelial migration ofPMN in vivo. PMN extravasting in response to a spatial gradient of chemoattractant diapedese by forming new adhesion at the leading front while simultaneously breaking adhesions in the uropod region. The enhanced binding of PMN to EC observed in the response to a temporal gradient of stimulant may be related to the formation of new adhesions at the leading edge of a migrating PMN, while loss of adhesivity after longer times ofincubation in stimulant may correspond to detachment of the uropod from the substrate. The adhesion of a migrating cell is ofnecessity transient, and we suggest that the CD11/CD18 molecules may mediate this transient adhesion .
Previous studies from this laboratory (9) showed that phorbol esters cause a transient change in the capacity of CD11b/CD18 to bind to C3bi-coated erythrocytes with a time course and magnitude identical with that shown here for adhesion to EC. These observations thus suggest that the binding site on CD11b/CD18 for EC is regulated in the same way as the binding site for C3bi. Since both CD11a/CD18 and CDllb/CD18 contribute to adhesion, these observations also suggest that not only CD11b/CD18 but also CD11a/CD18 is regulated in a transient fashion by phorbol esters .
Mechanism of Induced CD18 Function . Stimuli that enhance adhesion of PMN also cause an increase in the expression of CDllb/CD18 molecules on the cell surface (9, 10, 11; Figs . 7 and 8) . However, several observations suggest that this change in CD11b/CD18 expression cannot fully explain the changes observed in adhesivity. Phorbol esters caused no increase in CD11a/CD18 and only a three-fold increase in CDllb/CD18 expression, but adhesion to EC increased as much as 10-fold. More importantly, expression of CDllb/CD18 remained high during the subsequent drop in adhesivity (Figs. 4 and 7) . Thus, an additional mechanism unrelated to changes in surface expression may be at work to control CD11b/CD18-dependent adhesion .
The existence of such a mechansism is confirmed by observations on cytoplasts . These cell fragments did not alter expression of CDllb/CD18 molecules in response to stimulation with phorbol because they lacked intracellular pools of receptor (Tables I  and II , Fig. 9 ), yet they showed a rise and fall in adhesivity to EC in response to phorbol esters with a time course similar to that of whole cells. Thus changes in expression of CD18 are not necessary for either the initial rise or subsequent fall in CD18 function . We conclude that qualitative changes in existing receptors appear to be necessary and sufficient to control CD18-dependent adhesion . Alteration in surface expression of CDllb/CD18 may contribute to changes in adhesivity but a clear role for this phenomenon has yet to be determined. Other studies have explored the initial rise in CD18-dependent adhesivity ofPMN caused by chemotactic stimuli. Changes in the number of CD18 molecules on the cell surface were found not to correlate with enhanced aggregation of PMN (33) , enhanced binding of C3bi-coated particles (9), or enhanced binding to endothelium (34) . Our results confirm these findings, and extend them by showing that C1318-dependent adhesion of PMN to endothelium is transient, and that the decline in binding is not dependent upon changes in the number of CD18 molecules on the cell surface.
What is the nature of the qualitative change(s) in CD11/CD18? Proteolysis of cell surface receptors appears unlikely to participate since immunoprecipitation experiments showed no evidence of proteolysis ofCD11/CD18 accompanying loss of receptor activity (Lo, S. K., and S. D. Wright, unpublished observation), and PMN treated with C5a until they were no longer adherent were able to readhere when stimulated subsequently with PMA or TNF (Fig. 6) . The action of lytic enzymes contained within granules is also unlikely to contribute since granule-free cytoplasts show normal transient binding behavior. An alternative explanation is suggested by the recent work of Detmers et al. (35) , who found that CDllb/CD18 aggregates in the plane of the membrane in response to stimuli that enhance its binding capacity, and that aggregation is a prerequisite for binding. The time course of enhanced binding of PMN to EC (Fig. 4) and the CDllb/CD18-dependent binding of C3bi-coated erythrocytes to PMN (9) . It is thus possible that stimulation of PMN leads to aggregation of CD11/CD18 molecules, and that the aggregates mediate adhesion to EC.
Summary
Fluorescently labeled polymorphonuclear leukocytes (PMN) were used to measure adhesion to human umbilical vein endothelial cells (EC) cultured in vitro. Stimulation of PMN with phorbol dibutyrate (PDB), TNF, or C5a caused an increase in adhesion followed by a return to prestimulation levels of adhesion of longer times of incubation . Maximal adhesion of PMN to EC occurred rapidly in response to C5a (5 min) and more slowly with TNF or PDB (15 min) . PMN stimulated to adhere with C5a detached from EC by 15 min .
PMN from CD11/CD18-deficient patients and PMN incubated with anti-CD18 mAbs failed to bind to EC despite maximal stimulation . Anti-CDlla/CD18 and antiCDl1b/CD18 each partially inhibited adhesion, and a combination of these two reagents completely blocked adhesion. The adhesion we measured was therefore completely dependent on CDll/CD18, and CDlla/CD18 and CDllb/CD18 each contributed to adhesion. Stimuli that enhanced adhesion of PMN to EC also enhanced expression ofCD11b/CD18 on the cell surface, but the time course of expression correlated poorly with changes in adhesivity. To determine if changes in the expression of CDllb/CD18 are necessary for the changes in adhesivity, we used enucleate cytoplasts that did not increase expression of CDllb/CD18. Cytoplasts showed a normal rise and fall in adhesivity in response to PDB . We conclude that the transient adhesion of stimulated PMN to naive EC is regulated by changes in the nature of existing CD11/CD18 molecules on the PMN surface . Changes in expression of CDllb/CD18 may contribute to enhancement ofadhesivity, but a definite role for this phenomenon has yet to be established .
